Your browser doesn't support javascript.
loading
A Ki-67 Index to Predict Treatment Response to the Capecitabine/Temozolomide Regimen in Neuroendocrine Neoplasms: A Retrospective Multicenter Study.
Wang, Wei; Zhang, Yu; Peng, Ying; Jin, Kai-Zhou; Li, Yuan-Liang; Liang, Yao; Tan, Huang-Ying; Yu, Xian-Jun; Zhou, Zhi-Wei; Chen, Jie.
Affiliation
  • Wang W; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang Y; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Peng Y; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Jin KZ; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li YL; Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China.
  • Liang Y; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Tan HY; Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China.
  • Yu XJ; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhou ZW; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chen J; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, chen0jie@hotmail.com.
Neuroendocrinology ; 111(8): 752-763, 2021.
Article in En | MEDLINE | ID: mdl-32668427
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Outcome Assessment, Health Care / Neuroendocrine Tumors / Ki-67 Antigen / Capecitabine / Temozolomide / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Outcome Assessment, Health Care / Neuroendocrine Tumors / Ki-67 Antigen / Capecitabine / Temozolomide / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article